0.32 (-%)
As of Nov 21, 2024
Source:
Marinus Pharmaceuticals, Inc. is a commercial-stage pharmaceutical company dedicated to the development of innovative therapeutics for the treatment of seizure disorders, including rare genetic epilepsies and status epilepticus, which includes the use of ZTALMY.
| Country | United States |
| Headquarters | radnor, pennsylvania |
| Phone Number | (484) 801-4670 |
| Industry | manufacturing |
| CEO | Scott Braunstein, M.D. |
| Website | www.marinuspharma.com |